Paresh Kumar

Goodwin

Contact
View Bio
RSS

Latest Posts › FDA Approval

Share:

FDA Approvals and Applications Update

On October 22, 2021, the FDA approved Genentech’s SUSVIMO (ranibizumab injection) for wet age-related macular degeneration (AMD) based on positive results from an open-label Phase III study. According to the Genentech press...more

10/27/2021  /  FDA Approval , Food and Drug Administration (FDA) , Genentech , Janssen Pharmaceuticals , Pharmaceutical Industry , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide